NFKB1 and Alzheimer disease: Moreover, immunohistochemical analysis has suggested that levels of NF‐κB activity are increased in cholinergic neurons in the basal forebrains of patients with AD where its dysfunction and degeneration contribute greatly to cognitive impairment in AD 27.